Brief: Lifecore Biomedical Announces Cooperation Agreement With 22NW
July 1 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O :
* LIFECORE BIOMEDICAL ANNOUNCES COOPERATION AGREEMENT WITH
22NW
* LIFECORE BIOMEDICAL INC - TO ADD FOUR DIRECTORS TO BOARD
* LIFECORE BIOMEDICAL INC - 22NW SIGNS STANDSTILL AND
SUPPORT
AGREEMENT
* LIFECORE BIOMEDICAL: 22NW WILL WITHDRAW NOTICE OF
NOMINATIONS OF
DIRECTOR CANDIDATES AT 2023 ANNUAL MEETING
Source text for Eikon: ID:nGNX7k8TJf
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan